Vaccine Developers Feel Impacts of Being in Spotlight
Chris Lisinski9/17/20 3:20 PM
From left to right: messagingLAB founder and CEO Karl Schmieder; Bill and Melinda Gates Foundation Medical Research Institute Discovery Leader Jared Silverman; MilliporeSigma Head of Process Solutions Services Research and Development Audrey Chang; and consultant David Onions speak during a virtual panel on vaccine development Thursday. [Screenshot]
With pharmaceutical companies racing to find a COVID-19 vaccine and the world closely watching their progress, scientific experts stressed Thursday that the clinical trial process must play out in full before a safe immunization can reach the public.